DPP4 and diabetes mellitus: A few preclinical and clinical studies showed, improvement of cardiovascular health by using a combination of DPP-4 inhibitor and metformin in type 2 diabetic patient by improving endothelial dysfunction and vascular complications from diabetes by increasing number of CD34+ve EPCs and migratory capacity [29, 34].